Literature DB >> 12371909

Evidence-based decision making and asthma in the internet age: the tools of the trade.

A R Jadad1.   

Abstract

At the dawn of the Information Age, the practice of evidence-based decision making (EBDM) is still hindered by many important barriers related to the decision makers, to the evidence per se or to the health system. Some of these barriers, particularly those related to the distillation, dissemination and packaging of research evidence, could be overcome by recent and ongoing developments in portable/wearable computers, internet appliances, multimedia and wireless broadband internet traffic. This article describes specific EBDM-related tools, with emphasis on internet-enabled "how to" books; and tools to improve the quality of reporting research, to formulate questions; to search for evidence; to access journals, systematic reviews and guidelines; to interact with organizations promoting EBDM; and to tailor evidence to individual cases. However, thinking that all barriers to the practice of EBDM could be solved by fancy information technology is naïve. Barriers related to the generation, interpretation, integration and use of the evidence demand more complex and perhaps unfeasible solutions, as overcoming them will require substantial changes in the structure of the health system, in the politics of science and in the way in which humans think and behave.

Entities:  

Mesh:

Year:  2002        PMID: 12371909     DOI: 10.1034/j.1398-9995.57.s74.4.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  2 in total

1.  A communitywide intervention to improve outcomes and reduce disability among injured workers in Washington State.

Authors:  Thomas M Wickizer; Gary M Franklin; Robert D Mootz; Deborah Fulton-Kehoe; Roy Plaeger-Brockway; Diana Drylie; Judith A Turner; Terri Smith-Weller
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 2.  Interfacing computers and the internet with your allergy practice.

Authors:  Jonathan A Bernstein
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.